Why are Altamira Therapeutics (cyto) shares trading higher Thursday?

Altamira Therapeutics Ltd. (NASDAQ:CYTO) shares are trading higher Thursday after the company announced highlights from its NASAR clinical trial with Bentrio nasal spray were published in video format on the social media channels of the allergology journal, "Allergy." The Details:

When will Altamira release its half-year 2024 financial results?

Altamira plans to release its half-year 2024 financial results and business update report by the end of August 2024. The financial results will be presented for the first time in US Dollars, which the Company adopted as its new reporting currency, replacing the Swiss Franc.

Is Altamira partnering with AM-125?

Pursuing partnering opportunities with the AM-125 program in vertigo and / or other CNS indications Altamira continues to make progress with the planned partnering of its legacy asset AM-125, a patented nasal spray formulation of the histamine analog betahistine.

The World's Leading Crypto Trading Platform

Get my welcome gifts